FLASCO Spring Session

Panelists Offer an Insider Perspective of the Unstable Future of Genetic Testing Reimbursement

April 13, 2019

To begin a session on the reimbursement of genetic testing during the Florida Society of Clinical Oncology’s annual meeting in Kissimmee, Florida, incoming president Luis E. Raez, MD, put things in perspective: “I’ve been practicing for more than 30 years, and it used to be that when you would explain a treatment plan to a patient, they would ask if they’re going to respond to it and you would have to say ‘I don’t know.’ Now, with genetic testing, hopefully you can say ‘yes.’”

Collaboration to Ensure Access to Cancer Care Despite Increasing Cost Constraints

April 13, 2019

Making lifesaving but costly cancer therapies available to patients requires collaboration across the healthcare system, agreed a panel of stakeholders at the Business of Oncology Summit hosted by the Florida Society of Clinical Oncology.

Pioneers and Progress in Personalized Lung Cancer Treatment

April 12, 2019

The treatment of lung cancer with personalized medicine has come a long way in recent decades, but still more achievements remain to be seen, said Bruce Johnson, MD, FASCO, immediate past president of the American Society of Clinical Oncology, during his keynote speech opening the Business of Oncology Summit hosted by the Florida Society of Clinical Oncology in Kissimmee, Florida.

Dr Rick McDonough on the Benefits of Being a FLASCO Member

April 12, 2019

"By being a part of this membership, you get access to education, information, resources, [and] materials that are hopefully going to be helpful in the care of cancer patients," said Rick McDonough, MD, president of the Florida Society of Clinical Oncology (FLASCO).